Article Abstract

Minimal residual disease detection in pediatric acute myeloid leukemia: does flow cytometry score a point over molecular biology?

Authors: Adriano Venditti, Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Sergio Amadori

Abstract

In acute myeloid leukemia (AML), achievement of morphologic complete remission (RC) still remains the “gold standard” to make a judgment on treatment response and yet hematologists wonder about its utility in the era of minimal residual disease (MRD) detection.